The nuances in imaging techniques and the improved outcomes associated with optimum therapy have caused the American Joint Committee on Cancer (AJCC) to reevaluate the staging process in 2018.

**Primary Tumor (T)**

- **T0:**No primary tumor identified (but with EBV-positive cervical node)

- **Tis:**Carcinomain situ, no invasive tumor present

- **T1:**Tumor involves nasopharynx, oropharynx, and/or nasal cavity without parapharyngeal involvement

- **T2:**Tumor extension into the parapharyngeal spaces or adjacent soft tissue (pterygoids, prevertebral muscles)

- **T3:**Tumor involves bony skull base, pterygoid bones, paranasal sinuses, cervical vertebrae

- **T4:**Tumor involves intracranial extension, deficits of cranial nerves, hypopharynx, orbit, parotid gland, and/or soft tissue infiltration beyond the lateral surface of the lateral pterygoid

**Nodal metastasis (N)**

- **N0:**No involvement

- **N1:**Unilateral cervical or unilateral or bilateral retropharyngeal node(s), ≤ 6 cm in greatest dimension, all located above the caudal border of the cricoid cartilage

- **N2:**Bilateral cervical node(s), ≤ 6 cm in greatest dimension, all located above the caudal border of the cricoid cartilage

- **N3:**Unilateral or bilateral cervical node(s) > 6 cm in greatest dimension or located below the caudal border of the cricoid cartilage

**Distant Metastasis (M)**

- **M0:**No distant metastases

- **M1:**Distant metastases present

**Stage Grouping**

- **Stage 0:**T1s-N0-M0

- **Stage I:**T1-N0-M0

- **Stage II:**T1-N1-M0 and T2-N0, N1-M0

- **Stage III:**T1, T2, T3-N2-M0 and T3-N0, N1, N2-M0

- **Stage IVA:**T4-any N-M0 and Any T, N3-M0

- **Stage IVB:**Any T-any N, M1